FDA 483 - Distron Corporation - March 20, 2024

An FDA inspection of Distron Corporation, a medical device manufacturer in Attleboro Falls, MA, identified two significant observations. The firm failed to adequately establish procedures for controlling storage areas and stock rooms, specifically lacking identification for quarantine and release areas. Additionally, acceptance activities were not adequately documented, with a tested and approved item missing proper records and management approval.